F01 Novel Advances in Neuromodulation for Parkinson’s Disease Featured

1:30 PM - 3:00 PM Friday, July 16

Advances in treating movement disorders with neuromodulation therapies continues to advance. In this session, we will explore and compare the advantages and disadvantages of deep brain stimulation and focused ultrasound. An overview of engineering advancements and optimal patient selection will be presented in addition to an overview of deep brain stimulation in very early-stage Parkinson's Disease.

CME Credits: 1.5 AMA PRA Category 1 Credits^TM

Learning Objectives

Upon completion of this educational activity, participants should be able to:

Discuss new engineering advancements in deep brain stimulation.
Compare and contrast the advantages and disadvantages of deep brain stimulation versus focused ultrasound.
Describe the major findings supporting the conduct of a pivotal phase 3 trial of deep brain stimulation in very early-stage Parkinson’s Disease.
Summarize the optimal patient characteristics of Parkinson’s patients best suited to receive deep brain stimulation.